BNP Paribas Asset Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.8M | Sell |
276,984
-53,169
| -16% | -$9.18M | 0.12% | 181 |
|
|
2025
Q1 | $51.5M | Buy |
330,153
+13,573
| +4% | +$2.12M | 0.14% | 153 |
|
|
2024
Q4 | $43.6M | Buy |
316,580
+72,724
| +30% | +$10M | 0.11% | 199 |
|
|
2024
Q3 | $36.4M | Buy |
243,856
+80,746
| +50% | +$12.1M | 0.09% | 226 |
|
|
2024
Q2 | $22.2M | Buy |
163,110
+76,908
| +89% | +$10.5M | 0.06% | 274 |
|
|
2024
Q1 | $13M | Buy |
+86,202
| New | +$13M | 0.03% | 386 |
|
|
2022
Q3 | – | Sell |
-6,729
| Closed | -$626K | – | 903 |
|
|
2022
Q2 | $626K | Buy |
+6,729
| New | +$626K | ﹤0.01% | 829 |
|